Advertisement

Clinical Reviews in Allergy

, 1:327 | Cite as

Human mast cells and basophils-structure, function, pharmacology, and biochemistry

  • Robert P. Schleimer
  • Donald W. MacGlashan
  • Edward S. Schulman
  • Stephen P. Peters
  • G. Kenneth Adams
  • N. Franklin Adkinson
  • Lawrence M. Lichtenstein
Article
  • 58 Downloads

Keywords

Mast Cell Histamine Release Allergy Clin Immunol Human Mast Cell Human Basophil 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

References

  1. 1.
    MacGlashan DW Jr, Lichtenstein LM: The purification of human basophils. J Immunol 124:2519–2521, 1980PubMedGoogle Scholar
  2. 2.
    Schulman ES, MacGlashan DW Jr, Peters SP, Schleimer RP, Newball HH, Lichtenstein LM: Human lung mast cells: purification and characterization. J Immunol 129:2662–2667, 1982PubMedGoogle Scholar
  3. 3.
    MacGlashan DW Jr, Schleimer RP, Peters SP, Schulman ES, Adams GK III, Sobotka AK, Newball HH, Lichtenstein LM: Comparative studies of human basophils and mast cells. Fed Proc 42:2504–2509, 1983PubMedGoogle Scholar
  4. 4.
    Schleimer RP, Schulman ES, MacGlashan DW Jr, Peters SP, Adams GK III, Lichtenstein LM, Adkinson NF Jr: Effects of dexamethasone on mediator release from human lung fragments, and purified human lung mast cells. J Clin Invest, in pressGoogle Scholar
  5. 5.
    Dvorak AM, Galli SJ, Schulman ES, Lichtenstein LM, Dvorak HT: Basophil and mast cell degranulation. Ultrastructural analysis of mechanisms of mediator release. Fed Proc, in pressGoogle Scholar
  6. 6.
    Dvorak AM, Mihm MC, Dvorak HF: Degranulation of basophilic leukocytes in allergic contact dermatitis reactions in man. J Immunol 116:687–695, 1976PubMedGoogle Scholar
  7. 7.
    Askenase PW, Haynes D, Hayden BJ: Antibody-mediated basophil accumulations in cutaneous hypersensitivity reactions of guinea pigs. J Immunol 117:216–224, 1976PubMedGoogle Scholar
  8. 8.
    Rathwell TL, Dineen JK, Love RJ: The role of pharmacologically active amines in resistance to trichostrongylus colubiformis in the guinea pig. Immunology 21:925–938, 1971Google Scholar
  9. 9.
    Butterworth AE: The eosinophil and its role in immunity to helminth infection. Curr Top Microbiol Immunol 77:127–168, 1977PubMedGoogle Scholar
  10. 10.
    Kay AB, Stechschulte DJ, Austen KF: An eosinophil leukocyte chemotactic factor of anaphylaxis. J Exp Med 133:602–608, 1971PubMedCrossRefGoogle Scholar
  11. 11.
    Paterson NAM, Wasserman SI, Said JW, Austen KF: Release of chemical mediators from partially purified human lung mast cells. J Immunol 117:1356–1362, 1976PubMedGoogle Scholar
  12. 12.
    Katz G, Cohen S: Experimental evidence of histamine release in allergy. JAMA 117:1782–1794, 1941Google Scholar
  13. 13.
    Hook WA, Siraganian RP: Complement induced histamine release from human basophils. HI. Effect of pharmacologic agents. J Immunol 118:679–684, 1977PubMedGoogle Scholar
  14. 14.
    Thueson DD, Speck LS, Lett-Brown MA, Grant JA: Histamine-releasing activity (HRA). I. Production by mitogen- or antigen-stimulated human mononuclear cells. J Immunol 123:626–632, 1979PubMedGoogle Scholar
  15. 15.
    Theoharides TC, Douglas WW: Somatostatin-induced histamine release in rat mast cells. Endocrinology 102:1637–1641, 1978PubMedCrossRefGoogle Scholar
  16. 16.
    Kops SK, Tsakalos ND, Theoharides TC, Askenase, PW: Mast cell secretion of serotonin and histamine induced by parathyroid hormone. Fed Proc 41:622, 1982Google Scholar
  17. 17.
    Ida S, Hooks JJ, Siraganian RP, Notkins AL: Enhancement of IgE-mediated histamine release from human basophils by viruses: Role of interferon. J Exp Med 145:892–906, 1978CrossRefGoogle Scholar
  18. 18.
    Knauer KA, Kagey-Sobotka A, Adkinson NF, Lichtenstein LM: Platelet augmentation of basophil histamine release. J Allergy Clin Immunol 69:152, 1982CrossRefGoogle Scholar
  19. 19.
    Marquardt DL, Parker DW, Sullivan TJ: Potentiation of mast cell mediator release by adenosine. J Immunol 120:871–878, 1978PubMedGoogle Scholar
  20. 20.
    Peters SP, Schulman ES, Schleimer RP, MacGlashan DW Jr, Newball HH, Lichtenstein LM: Dispersed human lung mast cells: Pharmacology and comparison with human lung tissue fragments. Am Rev Resp Dis 126:1034–1039, 1982PubMedGoogle Scholar
  21. 21.
    Peters SP, Schleimer RP, Kagey-Sobotka A, Naclerio RM, MacGlashan DW Jr, Schulman ES, Adkinson NF Jr, Lichtenstein LM: The role of prostaglandin D2 in IgE-mediated reactions in man. Trans Assoc Am Physicians XCV:221–228, 1982Google Scholar
  22. 22.
    Peters SP, Siegel MI, Sobotka AK, Lichtenstein LM: Lipoxygenase products modulate histamine release in human basophils. Nature 292:455–457, 1981PubMedCrossRefGoogle Scholar
  23. 23.
    Siraganian RP, Hook WA: Mechanism of histamine release by formyl methionine-containing peptides. J Immunol 119:2078–2083, 1977PubMedGoogle Scholar
  24. 24.
    Schleimer RP, Gillespie E, Lichtenstein LM: Release of histamine from human leukocytes stimulated with the tumor promoting phorbol diesters. I. Characterization of the response. J Immunol 126:570–574, 1981PubMedGoogle Scholar
  25. 25.
    Schleimer RP, Gillespie E, Daiuta R, Lichtenstein LM: Release of histamine from human leukocytes stimulated with the tumor-promoting phorbol diesters. II. Interaction with other stimuli. J Immunol 128:136–140, 1982PubMedGoogle Scholar
  26. 26.
    Tung R, Lichtenstein LM: In vitro histamine release from basophils of asthmatic and atopic individuals in D2O. J Immunol 128:2067–2072, 1982PubMedGoogle Scholar
  27. 27.
    Lichtenstein LM, Foreman JC, Conroy MC, Marone G, Newball HH: Differences between histamine release from rat mast cells and human basophils and mast cells, in Pepys J, Edwards AM (eds): The Mast Cell—Its Role in Health and Disease. Kent, England, Pittman Med Publ Co, Ltd, 1979, pp 83–96Google Scholar
  28. 28.
    Marone G, Findlay SR, Lichtenstein LM: Adenosine receptor on human basophils: modulation of histamine release. J Immunol 123:1473–1477, 1979PubMedGoogle Scholar
  29. 29.
    Schleimer RP, Peters SP, Sobotka AK, Lichtenstein LM: Lipoxygenase products release histamine from human basophils, (submitted)Google Scholar
  30. 30.
    Lichtenstein LM: The immediate allergic response: In vitro separation of antigen activation, decay and histamine release. J Immunol 107:1122–1130, 1971PubMedGoogle Scholar
  31. 31.
    Siraganian RP, Hook WA: Mechanisms of histamine release by formyl methionine containing peptides. J Immunol 119:2078–2083, 1977PubMedGoogle Scholar
  32. 32.
    MacGlashan DW Jr, Lichtenstein LM: The transition from specific to nonspecific desensitization in human basophils. J Immunol 127:2410–2414, 1981PubMedGoogle Scholar
  33. 33.
    MacGlashan DW Jr, Lichtenstein LM: Studies of antigen binding to human basophils. I. Antigen binding and functional consequences. J Immunol 130:2330–2336, 1983PubMedGoogle Scholar
  34. 34.
    MacGlashan DW Jr, Mogowski M, Lichtenstein LM: Studies of antigen binding to human basophils. II. Continued expression of antigen-specific IgE during antigen-induced desensitization. J Immunol 130:2337–2342, 1983PubMedGoogle Scholar
  35. 35.
    Kazimierczak W, Meier HL, MacGlashan DW Jr, Lichtenstein LM: An antigen-activated DFP-inhibitable enzyme controls basophil desensitization. (submitted)Google Scholar
  36. 36.
    Pepys J, Edwards AM, (eds): The Mast Cell-Its Role in Health and Disease. Kent, England, Pittman Med Publ Co Ltd, 1979Google Scholar
  37. 37.
    Dale HH, Laidlow PP: J Physiol (London) 52:355, 1919Google Scholar
  38. 38.
    Lichtenstein LM, Norman PS: Human allergic reactions. Am J Med 46:163–173, 1969PubMedCrossRefGoogle Scholar
  39. 39.
    Bhat KN, Arroyave CM, Martey SR Jr, Stevenson DD, Thor EM: Plasma histamine changes during provoked bronchospasm in asthmatic patients. J Allergy Clin Immunol 58:247–256, 1976CrossRefGoogle Scholar
  40. 40.
    Atkins PC, Norman ME, Zweiman B: Antigen-induced neutrophil chemotactic activity in man: Correlation with bronchospasm and inhibition by disodium cromoglycate. J Allergy Clin Immunol 62:149–155, 1978PubMedCrossRefGoogle Scholar
  41. 41.
    Knauer KA, Lichtenstein LM, Adkinson NF Jr, Fish JE: Platelet activation during antigen-induced airway reactions in asthmatic subjects. New Engl J Med 304:1404–1407, 1981PubMedGoogle Scholar
  42. 42.
    Mergan DJR, Phillips MJ, Moodley I, Elliot EV, Davies RJ: Histamine, neutrophil chemotactic factor, and circulating basophil levels following exercise in asthmatic and control subjects. Clin Allergy 12(supplement):29–37, 1982Google Scholar
  43. 43.
    Dorsch W, Ring J, Reimann HJ, Geiger R: Mediator studies in skin blister fluid from patients with dual skin reactions after intradermal allergen injection. J Allergy Clin Immunol 70:236–242, 1982PubMedCrossRefGoogle Scholar
  44. 44.
    Eggleston PA, Handley JO, Gwaltney JM, Eggleston AW, Leavell BS: Histamine in nasal secretions. Int Arch Allergy Appl Immunol 57:193–197, 1978PubMedGoogle Scholar
  45. 45.
    Naclerio RM, Meier HL, Kagey-Sobotka A, Adkinson NF, Meyers DA, Norman PS, Lichtenstein LM: Mediator release after nasal airway challenge with allergen. Eur J Respir Dis, in pressGoogle Scholar
  46. 46.
    Pienkowski M et al. (In preparation)Google Scholar
  47. 47.
    Gleich GJ: The late phase of the immunoglubin E-mediated reaction: A link between anaphylaxis and common allergic disease? J Allergy Clin Immunol 70:160–169, 1982PubMedCrossRefGoogle Scholar
  48. 48.
    Oertel H, Kaliner M: The biologic activity of mast cell granules in rat skin: Effects of adrenocorticosteroids on late-phase inflammatory responses induced by mast cell granules. J Allergy Clin Immunol 68:238–242, 1981PubMedCrossRefGoogle Scholar
  49. 49.
    Oertel HL, Kaliner M: The biological activity of mast cell granules. III. Purification of inflammatory factors of anaphylaxis (IF-A) responsible for causing late-phase reactions. J Immunol 127:1398–1402, 1981PubMedGoogle Scholar
  50. 50.
    Schild H: Q J Exp Physiol 1937; 26:165–181Google Scholar
  51. 51.
    Lichtenstein LM: The role of the cyclic AMP system in inflammation: An introduction, in Braun W, Lichtenstein LM, Parker CW (eds): Cyclic AMP, Cell Growth, and the Immune Response. New York, Springer Verlag, 1974, pp 147–162Google Scholar
  52. 52.
    Johnson AR, Moran NC: Inhibition of the release of histamine from rat mast cells: The effect of cold and adrenergic drugs on release of histamine by compound 48/80 and antigen. J Pharm Exp Ther 175:632–640, 1970Google Scholar
  53. 53.
    Lichtenstein LM, Gillespie E: Inhibition of histamine release by histamine controlled by H2 receptor. Nature 244:287–288, 1973PubMedCrossRefGoogle Scholar
  54. 54.
    Kaliner M: Human lung tissue and anaphylaxis: The effects of histamine on the immunologic release of mediators. Am Rev Respir Dis 118:1015–1022, 1978PubMedGoogle Scholar
  55. 55.
    Lichtenstein LM, DeBernardo R: The immediate allergic response: in vitro actions of cyclic AMP-active and other drugs on the two stages of histamine release. J Immunol 107:1131–1136, 1971PubMedGoogle Scholar
  56. 56.
    Londos L, Cooper DMF, Wolff J: Subclasses of external adenosine receptors. Proc Natl Acad Sri 77:2551–2554, 1980CrossRefGoogle Scholar
  57. 57.
    Lad PM, Nielson TB, Londos C, Preston MS, Rodbell M: Independent mechanisms of adenosine activation and inhibition of the turkey erythrocyte adenylate cyclase system. J Biol Chem 255:10841–10846, 1980PubMedGoogle Scholar
  58. 58.
    Holgate ST, Lewis RA, Austen KF: Role of adenylate cyclase in immunologic release of mediators from rat mast cells: Agonist and antagonist effects of purine and ribose modified adenosine analogs. Proc Natl Acad Sri 77:6800–6806, 1980CrossRefGoogle Scholar
  59. 59.
    Gronneberg R, Standberg K, Stalenheim G, Zetlerstrom O: Effect in man of anti-allergic drugs on the immediate and late phase cutaneous allergic reaction induced by anti-IgE. Allergy 36:201–207, 1981PubMedCrossRefGoogle Scholar
  60. 60.
    Poothullil J, Umemoto C, Dolovich J, Hargreave FE, Day RP: Inhibition by prednisone of late cutaneous allergic responses induced by antiserum to human IgE. J Allergy Clin Immunol 57:164–169, 1976PubMedCrossRefGoogle Scholar
  61. 61.
    Pepys J, Davies RJ, Breslin ABX, Hendrick DJ, Hutchcroft BJ: The effects of inhaled beclomethasone diproprionate (Becotide) and sodium cromoglycate on asthmatic reactions to provocation tests. Clin Allergy 4:13–24, 1974PubMedCrossRefGoogle Scholar
  62. 62.
    Pepys J: Effects of inhaled beclomethasone diproprionate on bronchial provocation test reactions. Postgrad Med J 51(Suppl 4):42, 1975PubMedGoogle Scholar
  63. 63.
    Pelikan Z: The effects of disodium cromoglycate and beclomethasone diproprionate on the late nasal mucosa response to allergen challenge. Ann Allergy 49:200–212, 1982PubMedGoogle Scholar
  64. 64.
    Norn S: Influence of antirheumatic agents on the release of histamine from rat peritoneal mast cells after an antigen-antibody reaction. Acta 22:369–378, 1965Google Scholar
  65. 65.
    Schmutzler W, Freundt GP: The effect of glucocorticoids and catecholamines on cyclic AMP and allergic histamine release in guinea pig lung. Int Arch Allergy Appl Immunol 49:209–212, 1975PubMedGoogle Scholar
  66. 66.
    Schleimer RP, Lichtenstein LM, Gillespie E: Inhibition of basophil histamine release by anti-inflammatory steroids. Nature 292:454–455, 1981PubMedCrossRefGoogle Scholar
  67. 67.
    Daeron M, Sterk AR, Hirata F, Ishizaka T: Biochemical analysis of glucocorticoid-induced inhibition of IgE-mediated histamine release from mouse mast cells. J Immunol 129:1212–1218, 1982PubMedGoogle Scholar
  68. 68.
    Schleimer RP, MacGlashan DW Jr, Gillespie E, Lichtenstein LM: Inhibition of basophil histamine release by anti-inflammatory steroids. II. Studies on the mechanism of action. J Immunol 129:1632–1636, 1982PubMedGoogle Scholar
  69. 69.
    Danon A, Assouline G: Inhibition of prostaglandin biosynthesis by corticosteroids requires RNA and protein synthesis. Nature 273:552–554, 1978PubMedCrossRefGoogle Scholar
  70. 70.
    Flower RJ, Blackwell GJ: Antiinflammatory steroids induce biosynthesis of a phospholipase A2 inhibitor which prevents prostaglandin generation. Nature 278:456–459, 1979PubMedCrossRefGoogle Scholar
  71. 71.
    Hirata F, Schiffmann E, Venkatasubramanian K, Salomon D, Axelrod J: A phospholipase A2 inhibitory protein in rabbit neutrophils induced by glucocorticoids. Proc Natl Acad Sci 77:2533–2536, 1980PubMedCrossRefGoogle Scholar
  72. 72.
    Gryglewski RJ, Panczenko B, Korbut R, Grodzinska L, Ocetkiewicz A: Corticosteroids inhibit prostaglandin release from perfused mesenteric blood vessels of rabbit and from perfused lungs of sensitized guinea pig. Prostaglandins 10:343–355, 1975PubMedGoogle Scholar
  73. 73.
    Hong SL, Levine L: Inhibition of arachidonic acid release from cells as the biochemical action of antiinflammatory corticosteroids. Proc Natl Acad Sci 73:1730–1734, 1976PubMedCrossRefGoogle Scholar
  74. 74.
    Kuehl FA, Egan RW: Prostaglandins, arachidonic acid, and inflammation. Science 210:978–984, 1980PubMedCrossRefGoogle Scholar
  75. 75.
    Sullivan TJ, Parker CW: Possible role of arachidonic acid and its metabolites in mediator release from rat mast cells. J Immunol 122:431–436, 1979PubMedGoogle Scholar
  76. 76.
    Marone G, Sobotka AK, Lichtenstein LM: Effects of arachidonic acid and its metabolites on antigen induced histamine release from human basophils in vitro. J Immunol 123:1669–1677, 1979PubMedGoogle Scholar
  77. 77.
    Peters SP, Kagey-Sobotka A, MacGlashan DW Jr, Siegel MI, Lichtenstein LM: The modulation of human basophil histamine release by products of the 5-lipoxygenase pathway. J Immunol 129:797–803, 1982PubMedGoogle Scholar
  78. 78.
    Marone G, Kagey-Sobotka A, Lichtenstein LM: Possible role of phospholipase A2 in triggering histamine secretion from human basophils in vitro. Clin Immunol Immunopathol 20:231–239, 1981PubMedCrossRefGoogle Scholar
  79. 79.
    Stenson WF, Parker CW, Sullivan TJ: Augmentation of IgE-mediated release of histamine by 5-hydroxyeicosatetraenoic acid and 12-hydroxyeicosatetraenoic acid. Biochem Biophys Res Comm 96:1045–1052, 1980PubMedCrossRefGoogle Scholar
  80. 80.
    Marone G, MacGlashan DW Jr, Kagey-Sobotka A, Lichtenstein LM: Desensitization and phospholipid metabolism in human basophils, in Oehting A (ed): Advances in Allergology and Immunology. New York, Pergamon Press, 1980Google Scholar
  81. 81.
    Bach MK: A molecular theory to explain the mechanisms of allergic histamine release. J Theor Biol 45:131–151, 1974PubMedCrossRefGoogle Scholar
  82. 82.
    Foreman JC, Mongar JL, Gomperts BD, Garland LG: A possible role for cyclic AMP in the regulation of histamine secretion and the action of cromoglycate. Biochem Pharmacol 24:538–540, 1975PubMedCrossRefGoogle Scholar
  83. 83.
    Roy AC, Warren BT: Inhibition of cAMP phosphodiesterase by disodium cromoglycate. Biochem Pharmacol 23:917–920, 1974PubMedCrossRefGoogle Scholar
  84. 84.
    Theoharides TC, Sieghart W, Greengard P, Douglas WW: Antiallergic drug cromolyn may inhibit histamine secretion by regulating phosphorylation of a mast cell protein. Science 207:80–82, 1980PubMedCrossRefGoogle Scholar
  85. 85.
    Conrad DM, Bazin H, Sehon AH, Froese A: Binding parameters between rat IgE and rat mast cell receptors. J Immunol 114:1688–1691, 1975PubMedGoogle Scholar
  86. 86.
    Metzger H, Geetze A, Kanellopoulos J, Fewtrell C: Structure of the high affinity mast cell receptor for IgE. Fed Proc 41:8–11, 1982PubMedGoogle Scholar
  87. 87.
    Foreman JC, Hallett MB, Mongar JL:45Calcium uptake in rat peritoneal mast cells. Br J Pharmacol 55:283–284, 1975Google Scholar
  88. 88.
    Kennedy DA, Sullivan TJ, Parker CW: Activation of phospholipid metabolism during mediator release from stimulated rat mast cells. J Immunol 122:152–159, 1979Google Scholar
  89. 89.
    Crews FT, Morita Y, Hirata F, Axelrod J, Siraganian RP: Phospholipid methylarion affects immunoglobulin E-mediated histamine and arachidonic acid release in rat leukemic basophils. Biochem Biophys Res Comm 93:42–49, 1980PubMedCrossRefGoogle Scholar
  90. 90.
    Ishizaka T, Hirata F, Ishizaka K, Axelrod J: Stimulation of phospholipid methylarion Ca+ + influx, and histamine release by bridging of IgE receptors on rat mast cells. Proc Natl Acad Sci 77:1903–1906, 1980PubMedCrossRefGoogle Scholar
  91. 91.
    Ishizaka T: Analysis of triggering events in mast cells for immunoglobulin E-mediated histamine release. J Allergy Clin Immunol 67:90–96, 1981PubMedCrossRefGoogle Scholar
  92. 92.
    Michell RH: Inositol phospholipids and cell surface function. Biochem Biophys Acta 415:81–147, 1975PubMedGoogle Scholar
  93. 93.
    Rittenhouse-Simmons S: Production of diglyceride from phosphatidylinositol in activated human platelets. J Clin Invest 63:580–587, 1979PubMedCrossRefGoogle Scholar
  94. 94.
    Kennedy DA, Sullivan TJ, Sylvester P, Parker CW: Diacylglycerol metabolism in mast cells: A potential role in membrane fusion and arachidonic acid release. J Exp Med 150:1039–1044, 1979CrossRefGoogle Scholar
  95. 95.
    Kennedy DA, Secosan CJ, Parker CW, Sullivan TJ: Modulation of stimulated phospholipid metabolism in mast cells by pharmacologic agents that increase cyclic 3′,5′-adenosine monophosphate levels. J Immunol 123:1519–1524, 1979Google Scholar
  96. 96.
    Morita Y, Chiang PK, Siraganian RP: Effect of inhibitors of transmethylation on histamine release from human basophils. Biochem Pharm 30:785–791, 1981PubMedCrossRefGoogle Scholar
  97. 97.
    Bell RL, Kennedy DO, Stanford N, Majerus PW: Diglyceride lipase: A pathway for arach-idonate release from human platelets. Proc Natl Acad Sci 76:3238–3241, 1979PubMedCrossRefGoogle Scholar
  98. 98.
    Lapetina EG, Billah MM, Cuatrecasas P: The phosphatidylinositol cycle and the regulation of arachidonic acid production. Nature 292:367–369, 1981PubMedCrossRefGoogle Scholar
  99. 99.
    Crews FT, Morita Y, McGivney A, Hirata F, Siraganian RP, Axelrod J: IgE mediated histamine release in rat basophilic leukemia cells. Receptor activation, phospholipid methylarion, Ca flux, and release of arachidonic acid. Arch Biochem Biophys 212:561–571, 1981PubMedCrossRefGoogle Scholar
  100. 100.
    Foreman JC, Hallett MB, Mongar JL: The relationship between histamine secretion and45calcium uptake by mast cells. J Physiol 271:193–214, 1977PubMedGoogle Scholar
  101. 101.
    Pruzansky JJ, Patterson R: The diisopropylfluorophosphate inhibitable step in antigen induced histamine release from human leukocytes. J Immunol 114:939–943, 1975PubMedGoogle Scholar
  102. 102.
    Kaliner M, Austen KF: A sequence of biochemical events in the antigen-induced release of chemical mediators from sensitized human lung tissue. J Exp Med 138:1077–1086, 1973PubMedCrossRefGoogle Scholar
  103. 103.
    Taurog JD, Fewtrell C, Becker EL: IgE-mediated triggering of rat basophilic leukemia cells: Lack of evidence for serine esterase activation. J Immunol 122:2150–2155, 1979PubMedGoogle Scholar
  104. 104.
    Walenga R, Vanderhoek JY, Feinstein MB: Serine esterase inhibitors block stimulus-induced mobilization of arachidonic acid and phosphatidylinositide-specific phospholipase C activity in platelets. J Biol Chem 255:6024–6027, 1980PubMedGoogle Scholar
  105. 105.
    Lichtenstein LM, Margolis S: Histamine release in vitro: Inhibition by catecholamines and methylxanthines. Science 161:902–903, 1968PubMedCrossRefGoogle Scholar
  106. 106.
    Gillespie E: Compound 48/80 decreases adenosine 3′,5′-monophosphate formation in rat peritoneal mast cells. Experientia 29:447–448, 1972CrossRefGoogle Scholar
  107. 107.
    Kaliner M, Austen KF: Cyclic AMP, ATP, and reversed anaphylactic histamine release from rat mast cells. J Immunol 112:664, 1974PubMedGoogle Scholar
  108. 108.
    Sullivan TJ, Parker KL, Kulczycki A, Parker CW: Modulation of cyclic AMP in purified rat mast cells. III. Studies on the effects of concanavalin A and anti-IgE on cyclic AMP concentrations during histamine release. J Immunol 117:713–716, 1976PubMedGoogle Scholar
  109. 109.
    Lewis RA, Holgate ST, Roberts LJ, Maguire JF, Oates JA, Austen KF: Effects of indomethacin on cyclic nucleotide levels and histamine release from rat serosal mast cells. J Immunol 123:1663–1668, 1979PubMedGoogle Scholar
  110. 110.
    Ishizaka T, Hirata F, Sterk AR, Ishizaka K, Axelrod JA: Bridging of IgE receptors activates phospholipid methylation and adenylate cyclase in mast cell plasma membranes. Proc Natl Acad Sri 78:6812–6816, 1981CrossRefGoogle Scholar
  111. 111.
    Hempstead BL, Kulczycki A, Parker CW: Phosphorylation of the IgE receptor from ionophore A23187 stimulated intact rat mast cells. Biochem Biophys Res Comm 98:815–822, 1981PubMedCrossRefGoogle Scholar
  112. 112.
    Holgate ST, Lewis RA, Austen KF: 3′,5′-cyclic adenosine monophosphate-dependent protein kinase of the rat serosal mast cell and its immunologic activation. J Immunol 124:2093–2099, 1980PubMedGoogle Scholar
  113. 113.
    Winslow CM, Lewis RA, Austen KF: Mast cell mediator release as a function of cyclic AMP-dependent protein kinase activation. J Exp Med 154:1123–1125, 1981CrossRefGoogle Scholar
  114. 114.
    Kishimoto A, Takai Y, Mori T, Kikkawa U, Nishizuka Y: Activation of calcium and phos-pholipid-dependent protein kinase by diacylglycerol, its possible relation to phosphatidylinositol turnover. J Biol Chem 255:2273–2276, 1980PubMedGoogle Scholar
  115. 115.
    Gillespie E, Lichtenstein LM: Heavy water enhances IgE-mediated histamine release from human leukocytes. Evidence for microtubule involvement. PSEBM 140:1228–1230, 1970Google Scholar
  116. 116.
    Adelstein RS, Conti MA: Phosphorylation of platelet myosin increases actin-activated myosin ATPase activity. Nature 256:597–598, 1975PubMedCrossRefGoogle Scholar

Copyright information

© Humana Press Inc. 1983

Authors and Affiliations

  • Robert P. Schleimer
    • 1
  • Donald W. MacGlashan
    • 1
  • Edward S. Schulman
    • 1
  • Stephen P. Peters
    • 1
  • G. Kenneth Adams
    • 1
  • N. Franklin Adkinson
    • 1
  • Lawrence M. Lichtenstein
    • 1
  1. 1.Division of Clinical Immunology, Department of MedicineJohns Hopkins University of School of MedicineBaltimore

Personalised recommendations